Sabra Health Care REIT, Inc.
NASDAQ:SBRAREIT - Healthcare Facilities
-$0.11 today
- Market cap
- $5.40B
- Beta
- 0.63
- P/E (TTM)
- 29.0
- EPS (TTM)
- $0.62
- Dividend yield
- 6.69%
Volume 2.42M
Average 2.46M
SBRA EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
Sabra Health Care REIT, Inc.NASDAQ: SBRA
EPS (Diluted) · Q2 FY2026 · quarter ended Jun 2026
EPS (Diluted) turns negative
Q2 FY2026 EPS (Diluted) was -$0.1, compared with $0.27 a year earlier. Trailing-twelve-month EPS (Diluted) was $0.26.
Context
- EPS (Diluted) increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 6 analysts of $0.35 (-45.7%) for the fiscal year ending Dec 2026, a slowdown from the +18.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- -$0.1-162.5% QoQ
- Last fiscal yearDec 2025
- $0.64+18.5% YoY
- LTMJun 2026
- $0.26-65.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -137.0% | +77.1% | +214.2 pp |
| 1 year | +18.5% | -45.7% | -64.2 pp |
| 3-year CAGR | — | +5.0% | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 0.64 USD
- Year-over-year change
- +18.5%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0.64 | +18.5% |
| FY2024 | 2024-12-31 | 0.54 | +813.7% |
| FY2023 | 2023-12-31 | 0.06 | +117.4% |
| FY2022 | 2022-12-31 | (0.34) | +34.6% |
| FY2021 | 2021-12-31 | (0.52) | — |
EPS (Diluted) vs competitors
How SBRA compares with its peers on the latest reported figures
- SBRA's LTM Jun 2026 EPS (Diluted) of $0.26 is the 7th highest of the 11 companies compared; the peer median is $0.51.
- Its year-over-year change of -65.5% is the lowest of 8, against a peer median of +99.3%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | $14.24 | +349.2% | +80.9% | |
| LTM Jun 2026 | $2.8 | +72.8% | +2.5% | |
| LTM Sep 2026 | $2.03 | +41.0% | +66.7% | |
| LTM Sep 2026 | $1.61 | +20.1% | — | |
| LTM Sep 2026 | $0.52 | +1001.2% | -52.3% | |
| LTM Sep 2026 | $0.49 | +255.1% | — | |
| LTM Jun 2026 | $0.26 | -65.5% | — | |
NHPBPNational Healthcare Properties, Inc. | LTM Mar 2026 | $0 | — | — |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | -$0.02 | +99.3% | — |
| FY2025 | -$0.34 | — | — | |
NHPNational Healthcare Properties, Inc. (NHP) | LTM Dec 2025 | -$2.51 | — | — |
| Peer median (excluding SBRA) | $0.51 | +99.3% | +34.6% | |
Competitors are the stored peer set for SBRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 569.55M | 624.81M | 647.51M | 703.24M | 774.63M |
| Cost of Revenue | 141.2M | 162.61M | 195.25M | 227.09M | 271.11M |
| Gross Profit | 428.34M | 462.2M | 452.27M | 476.15M | 503.53M |
| Gross Margin | 75.2% | 74.0% | 69.8% | 67.7% | 65.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 34.67M | 39.57M | 47.47M | 50.07M | 53.71M |
| Operating Expenses | 217.6M | 227.36M | 230.56M | 219.12M | 239.66M |
| Depreciation & Amortization | 178.99M | 187.78M | 183.09M | 169.62M | 187M |
| EBITDA | 166.21M | 216.89M | 311.81M | 412.61M | 456.83M |
| EBITDA Margin | 29.2% | 34.7% | 48.2% | 58.7% | 59.0% |
| Operating Income | 210.75M | 234.84M | 221.71M | 257.03M | 263.87M |
| Operating Margin | 37.0% | 37.6% | 34.2% | 36.5% | 34.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 98.63M | 105.47M | 112.96M | 115.27M | 112.49M |
| Other Income / Expenses | (322.16M) | (311.21M) | (205.95M) | (129.31M) | (106.52M) |
| Income Before Tax | (111.41M) | (76.36M) | 15.76M | 127.72M | 157.35M |
| Pre-Tax Margin | -19.6% | -12.2% | 2.4% | 18.2% | 20.3% |
| Income Tax Expense | 1.85M | 1.24M | 2M | 1.01M | 1.84M |
| Net Income | (113.26M) | (77.61M) | 13.76M | 126.71M | 155.61M |
| Net Margin | -19.9% | -12.4% | 2.1% | 18.0% | 20.1% |
| EPS (Basic) | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
| EPS (Diluted) | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
| Weighted Avg Shares | 219.07M | 230.95M | 231.2M | 233.5M | 241.31M |
| Weighted Avg Shares (Diluted) | 219.07M | 230.95M | 232.79M | 236.05M | 244.5M |
Sabra Health Care REIT, Inc.
NASDAQ:SBRA
Intrinsic Alpha fair value
Locked
Current Price
$20.62
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.